# Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

> **NCT02461134** · PHASE2 · TERMINATED · sponsor: **Actelion** · enrollment: 1 (actual)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **DRUG:** Ponesimod

## Key facts

- **NCT ID:** NCT02461134
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-29
- **Primary completion:** 2017-03-02
- **Final completion:** 2017-03-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461134, "Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT02461134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*